Paper33767404
Natural killer cell alloreactivity in HLA-haploidentical hematopoietic transplantation: a study on behalf of the CTIWP of the EBMT.
Ruggeri L and 19 others. Bone Marrow Transplant, 2021. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. Natural killer cell alloreactivity in HLA-haploidentical hematopoietic transplantation: a study on behalf of the CTIWP of the EBMT. Papers, record 33767404. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33767404
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Natural killer cell alloreactivity in HLA-haploidentical hematopoietic transplantation: a study on behalf of the CTIWP of the EBMT.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Graft vs Host Disease | Major topic |
| Hematopoietic Stem Cell Transplantation | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Animals | |
| Humans | |
| Killer Cells, Natural | |
| Mice | |
| Prospective Studies | |
| Transplantation, Haploidentical |
Source PubMed
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28986344 | NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications. | Blood | 2018 | https://conductscience.org/library/papers/28986344 | PubMed |
| 2 | 12393440 | Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor. | Blood | 2002 | https://conductscience.org/library/papers/12393440 | PubMed |
| 3 | 9780338 | Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. | N Engl J Med | 1998 | https://conductscience.org/library/papers/9780338 | PubMed |
| 4 | 11896281 | Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. | Science | 2002 | https://conductscience.org/library/papers/11896281 | PubMed |
| 5 | 22918403 | Haploidentical hematopoietic stem cell transplantation with unmanipulated granulocyte colony stimulating factor mobilized marrow and blood grafts. | Curr Opin Hematol | 2012 | https://conductscience.org/library/papers/22918403 | PubMed |
| 6 | 26130705 | Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia. | Blood | 2015 | https://conductscience.org/library/papers/26130705 | PubMed |
| 7 | 14688377 | Determinants of antileukemia effects of allogeneic NK cells. | J Immunol | 2004 | https://conductscience.org/library/papers/14688377 | PubMed |
| 8 | 26256941 | Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation. | Biol Blood Marrow Transplant | 2015 | https://conductscience.org/library/papers/26256941 | PubMed |
| 9 | 16864058 | The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry. | Biol Blood Marrow Transplant | 2006 | https://conductscience.org/library/papers/16864058 | PubMed |
| 10 | 22949046 | The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach. | Nat Rev Clin Oncol | 2012 | https://conductscience.org/library/papers/22949046 | PubMed |
| 11 | 17371948 | Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. | Blood | 2007 | https://conductscience.org/library/papers/17371948 | PubMed |
| 12 | 29793748 | NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia. | Trends Immunol | 2018 | https://conductscience.org/library/papers/29793748 | PubMed |
| 13 | 25769621 | Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality. | Blood | 2015 | https://conductscience.org/library/papers/25769621 | PubMed |
| 14 | 10381530 | Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. | Blood | 1999 | https://conductscience.org/library/papers/10381530 | PubMed |
| 15 | 20538804 | Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. | Blood | 2010 | https://conductscience.org/library/papers/20538804 | PubMed |
| 16 | 28588018 | Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion. | Blood | 2017 | https://conductscience.org/library/papers/28588018 | PubMed |
| 17 | 23423745 | T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation. | J Clin Oncol | 2013 | https://conductscience.org/library/papers/23423745 | PubMed |
| 18 | 26660427 | Hematopoietic stem cell transplantation for patients with AML in first complete remission. | Blood | 2016 | https://conductscience.org/library/papers/26660427 | PubMed |
| 19 | 23165479 | Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies. | Blood | 2013 | https://conductscience.org/library/papers/23165479 | PubMed |
| 20 | 15753458 | Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. | J Clin Oncol | 2005 | https://conductscience.org/library/papers/15753458 | PubMed |
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42712389 | Contrasting relapse rate associated with the absence of HLA-A3/A11 in T cell-replete haploidentical transplantation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42712389 | PubMed |
| 41603138 | Chimerism and a framework for clinical practice: A report from the Cellular Therapies Section Coordinating Committee (CTSCC) of Association for Advancement of Blood and Biotherapies (AABB). | Transfusion | 2026 | https://conductscience.org/library/papers/41603138 | PubMed |
| 41375063 | Natural Killer (NK) Cell-Based Therapies Have the Potential to Treat Ovarian Cancer Effectively by Targeting Diverse Tumor Populations and Reducing the Risk of Recurrence. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41375063 | PubMed |
| 41154342 | Allogeneic Hematopoietic Stem Cell Transplantation as a Platform to Treat Chemorefractory Acute Myeloid Leukemia in Adult Patients. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41154342 | PubMed |
| 41008790 | Influence of Genetic, Dietary, and Environmental Factors on Natural Killer (NK) Cell Biology and Function: Interplay Between NK Cell Activity and Cancer Onset or Progression. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41008790 | PubMed |
| 40934005 | Prediction and effect on relapse of natural killer cell alloreactivity based on KIR-HLA interactions in pediatric haploidentical transplantation with anti-thymoglobulin. | Front Immunol | 2025 | https://conductscience.org/library/papers/40934005 | PubMed |
| 40710344 | Natural Killer (NK) Cell Alloreactivity in Haploidentical Stem Cell Transplantation. | Cells | 2025 | https://conductscience.org/library/papers/40710344 | PubMed |
| 40317083 | Addressing graft-versus-host disease in allogeneic cell-based immunotherapy for cancer. | Exp Hematol Oncol | 2025 | https://conductscience.org/library/papers/40317083 | PubMed |
| 39229273 | Human leukocyte antigen evolutionary divergence as a novel risk factor for donor selection in acute lymphoblastic leukemia patients undergoing haploidentical hematopoietic stem cell transplantation. | Front Immunol | 2024 | https://conductscience.org/library/papers/39229273 | PubMed |
| 37398651 | Heterogeneity in functional genetic screens: friend or foe? | Front Immunol | 2023 | https://conductscience.org/library/papers/37398651 | PubMed |
| 36774947 | Effects of immune system cells in GvHD and corresponding therapeutic strategies. | Blood Res | 2023 | https://conductscience.org/library/papers/36774947 | PubMed |
| 36675576 | Human Leucocyte Antigen System and Selection of Unrelated Hematopoietic Stem Cell Donors: Impact of Patient-Donor (Mis)matching and New Challenges with the Current Technologies. | J Clin Med | 2023 | https://conductscience.org/library/papers/36675576 | PubMed |
| 36330529 | Lactate from the tumor microenvironment - A key obstacle in NK cell-based immunotherapies. | Front Immunol | 2022 | https://conductscience.org/library/papers/36330529 | PubMed |
| 36231109 | Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity. | Cells | 2022 | https://conductscience.org/library/papers/36231109 | PubMed |
| 35795036 | T-Cell Depleted Haploidentical Transplantation in Children With Hematological Malignancies: A Comparison Between CD3+/CD19+ and TCRαβ+/CD19+ Depletion Platforms. | Front Oncol | 2022 | https://conductscience.org/library/papers/35795036 | PubMed |
| 35740879 | Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy. | Biomolecules | 2022 | https://conductscience.org/library/papers/35740879 | PubMed |
| 35642633 | Harnessing allogeneic NK cells: improving outcomes with tailored donor lymphocyte infusion. | J Clin Invest | 2022 | https://conductscience.org/library/papers/35642633 | PubMed |
| 35327405 | Influence of Fetomaternal Microchimerism on Maternal NK Cell Reactivity against the Child's Leukemic Blasts. | Biomedicines | 2022 | https://conductscience.org/library/papers/35327405 | PubMed |
| 35054985 | A Hot Topic: Cancer Immunotherapy and Natural Killer Cells. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35054985 | PubMed |
| 35004548 | T-Cell-Replete Versus ex vivo T-Cell-Depleted Haploidentical Haematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukaemia and Other Haematological Malignancies. | Front Pediatr | 2021 | https://conductscience.org/library/papers/35004548 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33767404
GET https://conductscience.org/api/papers/v1/33767404/cited_by?page=2